Clinicopathologic characterization of ERK2 E322K mutation in solid tumors: Implications for treatment and drug development.
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Dazhi Liu, Yonina R. Murciano-Goroff, Justin Jee, Maria E. Arcila, Darren J. Buonocore, JianJiong Gao, Debyani Chakravarty, Alison M. Schram, Margaret K. Callahan, Claire Frances Friedman, Komal L. Jhaveri, James J. Harding, Mrinal M. Gounder, Ezra Rosen, Neal Rosen, Sandra Misale, Piro Lito, Rona Yaeger, Alexander E. Drilon, Bob T. Li
Institutions: Memorial Sloan Kettering Cancer Center, Cornell University
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
Funder: National Institutes of Health
OpenAlex ID: W4281854542
